Whether or not type I IFNs are necessary to drive HSV-1 from a lytic to a latent infection is currently unknown since CD118−/− mice succumb to infection even following the administration of neutralizing HSV-1 antibody or acyclovir treatment that stops HSV-1 replication in WT mice. The gene discussed is LIFR; the disease is disease arising from reactivation of latent virus.